Top 20 Life Sciences Deals of 2024 by Total Deal Value Shots: Life Sciences Dealmaking 2024 outlined a new genre of strategies for shaping global healthcare landscapes by targeting emerging technologies and addressing unmet needsIn 2024, Arrowhead’s global licensing and commercialization deal with Sarepta Therapeutics for $11.37B ranked first in the list, followed by…
Knowledge-packed, informative, and engaging, the Reuters Pharma 2024 event brimmed with enlightening sessions, presentations, and scientific orators shedding light on innovative therapies and unmet needs of the healthcare sector. Day 1 commenced with keynote speakers shedding light on next-generation customer engagement models, mastering patient-centric metrics, amplifying strategic voice, and expediting equitable access followed by a…

